Catheter Precision (VTAK) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to 0.27.
- Catheter Precision's Equity Ratio fell 4448.26% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year decrease of 4448.26%. This contributed to the annual value of 0.42 for FY2024, which is 3859.9% down from last year.
- Per Catheter Precision's latest filing, its Equity Ratio stood at 0.27 for Q3 2025, which was down 4448.26% from 0.27 recorded in Q2 2025.
- In the past 5 years, Catheter Precision's Equity Ratio registered a high of 0.8 during Q3 2021, and its lowest value of 0.27 during Q2 2025.
- For the 5-year period, Catheter Precision's Equity Ratio averaged around 0.59, with its median value being 0.66 (2024).
- As far as peak fluctuations go, Catheter Precision's Equity Ratio soared by 2719.21% in 2022, and later plummeted by 5171.6% in 2025.
- Over the past 5 years, Catheter Precision's Equity Ratio (Quarter) stood at 0.65 in 2021, then decreased by 15.35% to 0.55 in 2022, then rose by 25.36% to 0.69 in 2023, then plummeted by 38.6% to 0.42 in 2024, then crashed by 37.11% to 0.27 in 2025.
- Its Equity Ratio stands at 0.27 for Q3 2025, versus 0.27 for Q2 2025 and 0.32 for Q1 2025.